Background illustration for clinical trials search

Paid Clinical Trials Minnesota

Discover 1,919 paid clinical trials in Minnesota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

for
Small Cell Lung Cancer
Location: New York NY, Fairfax VA, Tampa FL, Zion IL, Memphis TN,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07531095

Phase 1, Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: New York NY, Philadelphia PA, Pittsburgh PA, Atlanta GA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT07012044

Phase 1, Recruiting

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

for
Medulloblastoma, Medulloblastoma, Childhood,
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 39

Code: NCT05057702

Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Boston MA, Hackensack NJ, New Brunswick NJ,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase 2, Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Boston MA, New York NY, Montreal, Washington D.C. DC,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Stellate Ganglion Block

for
Esophagectomy, Pneumonectomy, Lobectomy
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18 - 70+

Code: NCT06271707

Recruiting

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

for
Bradycardia, Heart Failure, Ventricular Dysfunction
Location: Charlottesville VA, Columbus OH, Chicago IL,
Sponsor: VDI Technologies

Sex: All

Age: 18+

Code: NCT06641362

Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

for
Carcinoma, Hepatocellular, Hepatocellular Cancer,
Location: Raleigh NC, Cary NC, Durham NC, Pittsburgh PA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227012

Phase 1, Phase 2, Recruiting

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

for
Glioblastoma, IDH-Wildtype,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07301268

Phase 2, Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Portsmouth VA, Norfolk VA, Bethesda MD, Richmond VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 45 - 70+

Code: NCT06995898

Recruiting

Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:

for
Pharmacogenomic Drug Interaction, Side Effect of Drug,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06322238

Phase 2, Recruiting

Real World Observational Study of Sotatercept for Pulmonary Hypertension

for
Pulmonary Hypertension
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06751082

Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Boston MA, Sherbrooke, Westbury NY, White Plains NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase 2, Phase 3, Recruiting

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness

for
Pulmonary Embolism Acute
Location: The Bronx NY, Buffalo NY, Kettering OH, Saint Cloud MN,
Sponsor: Angiodynamics, Inc.

Sex: All

Age: 18+

Code: NCT07280247

Recruiting

Abbott Cephea Mitral Valve Disease Registry

for
Mitral Regurgitation, Mitral Stenosis, Mitral Valve Disease,
Location: Roslyn NY, The Bronx NY, Norfolk VA, Charleston SC,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT07069673

Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for
Esophageal Squamous Cell Carcinoma
Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644781

Phase 3, Recruiting

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

for
Hypochondroplasia
Location: Baltimore MD, Washington D.C. DC, Chicago IL,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0 - 3

Code: NCT07126262

Phase 2, Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

for
Invasive Mold Infections
Location: New York NY, Philadelphia PA, Baltimore MD, Ottawa,
Sponsor: Basilea Pharmaceutica

Sex: All

Age: 18+

Code: NCT06925321

Phase 3, Recruiting

A Study of Bleeding and Treatment in Participants With Von Willebrand Disease

for
Von Willebrand Disease (VWD),
Location: Miami FL, Pittsburgh PA, Atlanta GA, Ann Arbor MI,
Sponsor: Hemab ApS

Sex: All

Age: 16+

Code: NCT06610201

Recruiting

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management

for
Type 2 Diabetes
Location: Minneapolis MN
Sponsor: Katherine Vickery

Sex: All

Age: 18+

Code: NCT07091487

Recruiting

Popular cities in Minnesota

Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.

These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.

Why choose Minnesota for clinical trials?

For people considering participation in a clinical trial, Minnesota provides distinct advantages. The state is home to a diverse and engaged population, which enriches the pool of participants and enhances the relevance of research findings. Minnesota is also renowned for its innovative healthcare landscape, highlighted by institutions that are at the forefront of medical research and technological advancements.

By choosing to participate in a clinical trial in Minnesota, participants can contribute to significant medical research while benefiting from a well-established and collaborative clinical research environment that prioritizes patient safety and care.

Common conditions studied in Minnesota

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Minnesota